跳至主要内容
临床试验/JPRN-UMIN000027783
JPRN-UMIN000027783已完成未知

An interventional study to assess patient-reported outcome measures in bradalumab treated patients with moderate to severe plaque psoriasis in Japan - PROMs in brodalumab treated patients with psoriasis in Japan

Kyowa Hakko Kirin Co., Ltd0 个研究点目标入组 74 人开始时间: 2017年6月16日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients with psoriatic erythroderma, pustular psoriasis and guttate psoriasis at the time of informed concent. 2)Patients with a severe infection or active tuberculosis at the time of informed concent. 3)Patients who are judged by the investigator or subinvestigator to be unsuitable for participation in this study. 4)Patients with joint symptoms at enrollment.

研究者

发起方
Kyowa Hakko Kirin Co., Ltd

相似试验